BioPorto A/S (THOXF)
USD 0.29
(0.0%)
USD 0.29
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 89.81 Million DKK | -17.33% |
| 2022 | 108.64 Million DKK | 33.7% |
| 2021 | 81.25 Million DKK | -42.08% |
| 2020 | 140.28 Million DKK | 228.68% |
| 2019 | 42.68 Million DKK | -35.53% |
| 2018 | 66.2 Million DKK | 0.91% |
| 2017 | 65.6 Million DKK | 29.55% |
| 2016 | 50.64 Million DKK | 3.36% |
| 2015 | 48.99 Million DKK | 31.56% |
| 2014 | 37.23 Million DKK | -28.17% |
| 2013 | 51.84 Million DKK | 185.19% |
| 2012 | 18.17 Million DKK | -14.46% |
| 2011 | 21.25 Million DKK | 1.33% |
| 2010 | 20.97 Million DKK | 3.74% |
| 2009 | 20.21 Million DKK | 5.54% |
| 2008 | 19.15 Million DKK | -43.49% |
| 2007 | 33.9 Million DKK | 605.98% |
| 2006 | 4.8 Million DKK | -66.8% |
| 2005 | 14.46 Million DKK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 71.44 Million DKK | -20.45% |
| 2024 Q2 | 131.53 Million DKK | 84.11% |
| 2023 Q1 | 85.29 Million DKK | -21.49% |
| 2023 Q2 | 112.08 Million DKK | 31.41% |
| 2023 Q4 | 89.81 Million DKK | -8.26% |
| 2023 Q3 | 97.9 Million DKK | -12.65% |
| 2023 FY | 89.81 Million DKK | -17.33% |
| 2022 Q3 | 133.57 Million DKK | -9.06% |
| 2022 Q4 | 108.64 Million DKK | -18.66% |
| 2022 Q1 | 163.25 Million DKK | 100.92% |
| 2022 Q2 | 146.87 Million DKK | -10.03% |
| 2022 FY | 108.64 Million DKK | 33.7% |
| 2021 FY | 81.25 Million DKK | -42.08% |
| 2021 Q1 | 121.37 Million DKK | -13.48% |
| 2021 Q3 | 100.69 Million DKK | -8.03% |
| 2021 Q4 | 81.25 Million DKK | -19.3% |
| 2021 Q2 | 109.47 Million DKK | -9.8% |
| 2020 Q3 | 58.05 Million DKK | -14.57% |
| 2020 Q1 | 27.52 Million DKK | -35.5% |
| 2020 FY | 140.28 Million DKK | 228.68% |
| 2020 Q4 | 140.28 Million DKK | 141.65% |
| 2020 Q2 | 67.95 Million DKK | 146.84% |
| 2019 Q1 | 54.71 Million DKK | -17.35% |
| 2019 FY | 42.68 Million DKK | -35.53% |
| 2019 Q2 | 76.41 Million DKK | 39.65% |
| 2019 Q4 | 42.68 Million DKK | -29.13% |
| 2019 Q3 | 60.22 Million DKK | -21.18% |
| 2018 Q3 | 35.88 Million DKK | -21.04% |
| 2018 Q2 | 45.45 Million DKK | -14.97% |
| 2018 Q1 | 53.45 Million DKK | -18.53% |
| 2018 FY | 66.2 Million DKK | 0.91% |
| 2018 Q4 | 66.2 Million DKK | 84.47% |
| 2017 Q3 | 31.96 Million DKK | -14.71% |
| 2017 FY | 65.6 Million DKK | 29.55% |
| 2017 Q2 | 37.47 Million DKK | -18.28% |
| 2017 Q1 | 45.86 Million DKK | -9.44% |
| 2017 Q4 | 65.6 Million DKK | 105.24% |
| 2016 Q1 | 44.06 Million DKK | -10.06% |
| 2016 Q4 | 50.64 Million DKK | 56.22% |
| 2016 FY | 50.64 Million DKK | 3.36% |
| 2016 Q3 | 32.41 Million DKK | -15.57% |
| 2016 Q2 | 38.39 Million DKK | -12.87% |
| 2015 Q1 | 32.81 Million DKK | -11.89% |
| 2015 FY | 48.99 Million DKK | 31.56% |
| 2015 Q4 | 48.99 Million DKK | -11.25% |
| 2015 Q3 | 55.2 Million DKK | 87.55% |
| 2015 Q2 | 29.43 Million DKK | -10.3% |
| 2014 Q2 | 44.16 Million DKK | -7.03% |
| 2014 Q1 | 47.5 Million DKK | -8.36% |
| 2014 FY | 37.23 Million DKK | -28.17% |
| 2014 Q3 | 41.21 Million DKK | -6.68% |
| 2014 Q4 | 37.23 Million DKK | -9.65% |
| 2013 Q1 | 12.12 Million DKK | -33.29% |
| 2013 Q4 | 51.84 Million DKK | -8.46% |
| 2013 FY | 51.84 Million DKK | 185.19% |
| 2013 Q2 | 16.78 Million DKK | 38.45% |
| 2013 Q3 | 56.63 Million DKK | 237.32% |
| 2012 FY | 18.17 Million DKK | -14.46% |
| 2012 Q2 | 13.72 Million DKK | -26.87% |
| 2012 Q4 | 18.17 Million DKK | 87.27% |
| 2012 Q1 | 18.76 Million DKK | -11.72% |
| 2012 Q3 | 9.7 Million DKK | -29.25% |
| 2011 Q2 | 15.79 Million DKK | -20.5% |
| 2011 Q4 | 21.25 Million DKK | -14.83% |
| 2011 Q3 | 24.95 Million DKK | 58.02% |
| 2011 Q1 | 19.86 Million DKK | -5.3% |
| 2011 FY | 21.25 Million DKK | 1.33% |
| 2010 Q4 | 20.97 Million DKK | -14.32% |
| 2010 Q1 | 17.55 Million DKK | -13.17% |
| 2010 FY | 20.97 Million DKK | 3.74% |
| 2010 Q3 | 24.48 Million DKK | 72.66% |
| 2010 Q2 | 14.17 Million DKK | -19.24% |
| 2009 Q4 | 20.21 Million DKK | 0.0% |
| 2009 FY | 20.21 Million DKK | 5.54% |
| 2008 FY | 19.15 Million DKK | -43.49% |
| 2007 FY | 33.9 Million DKK | 605.98% |
| 2006 FY | 4.8 Million DKK | -66.8% |
| 2005 FY | 14.46 Million DKK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -6977.305% |
| Arrayit Corporation | 1 Million USD | -8877.608% |
| Atlantic International Corp. | 4.43 Million USD | -1924.429% |
| Biocept, Inc. | 30.87 Million USD | -190.905% |
| Bioqual, Inc. | 56.58 Million USD | -58.711% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -38622.988% |
| DermTech, Inc. | 121.93 Million USD | 26.342% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 97.854% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | -405.19% |
| iMD Companies, Inc. | 190.13 Thousand USD | -47134.889% |
| IDenta Corp. | 1.52 Million USD | -5772.783% |
| Interpace Biosciences, Inc. | 13.02 Million USD | -589.74% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | -988.366% |
| InVitro International | 1.53 Million USD | -5754.667% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | -234.641% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -3884458.824% |
| Medical Imaging Corp. | 4.19 Million USD | -2042.629% |
| NovelStem International Corp. | 2.25 Million USD | -3883.551% |
| Optigenex Inc. | 1.88 Million USD | -4656.208% |
| PharmChem, Inc. | 2.76 Million USD | -3147.481% |
| Proteome Sciences plc | 14.58 Million USD | -515.733% |
| Response Genetics, Inc | 48.88 Million USD | -83.723% |
| Rennova Health, Inc. | 20.57 Million USD | -336.553% |
| RushNet, Inc. | 6.04 Million USD | -1385.068% |
| ScreenPro Security Inc. | 1.26 Million USD | -7020.178% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -18910.717% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -12718.204% |
| Todos Medical Ltd. | 15.26 Million USD | -488.269% |